ENTITY
Frontage Holdings

Frontage Holdings (1521 HK)

59
Analysis
Health CareChina
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
Refresh
bullishWuxi Biologics
23 Mar 2019 12:52

ECM Weekly (23 March 2019) - ESR, Sun Car, Ruhnn, CanSino, Frontage, Wuxi Bio, WiseTech,

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
20 Mar 2019 16:23

Frontage Holding (方达控股) IPO: Updates from 2018 Numbers

Frontage Holding, a contract research organization subsidiary of A-share listed Hangzhou Tigermed Consulting (300347 CH), re-filed to list on the...

Logo
756 Views
Share
03 Jan 2019 13:32

Viva Biotech (维亚生物) IPO: When CRO Becomes Early Stage Biotech Investor

Viva Biotechnology, a China-based drug discovery company, is seeking to raise USD 200m to list on the Hong Kong Stock Exchange. In this insight, we...

Logo
1.4k Views
Share
05 Nov 2018 16:28

Frontage Holding (方达控股) IPO: More Disclosure Needed to Understand Moat and Growth Prospect

Frontage Holding, a contract research organization subsidiary of A-share listed Hangzhou Tigermed Consulting (300347 CH), filed to list on the Hong...

Logo
1.1k Views
Share
x